Venebio Launches Tool to Help Reduce Opioid Overdoses: Initial adopters of Venebio Opioid Advisor include health plans and Medicaid-managed care plans in Virginia and New York

Venebio Group, a leader in personalized risk prediction algorithms, today announced that its risk-screening tool for opioid overdose, Venebio Opioid Advisor™ (VOA™), is now commercially available nationwide following the conclusion of its pilot phase. While much of the national attention around the opioid epidemic has focused on addiction, many unintentional […]

Study of U.S. Opioid Users Shows Venebio’s Overdose Risk Index to Have 90% Accuracy

A recent study published in Pain Medicine validates the strong performance of Venebio Group’s risk index tool — Venebio Opioid Advisor (VOA) — at predicting the likelihood of a life-threatening overdose in patients taking a prescription opioid. Prescription opioid sales quadrupled in the United States between 1999 and 2010 [1], […]

New Study Reveals Highest Risk Profiles for Opioid Overdose

Individuals suffering from a substance use disorder (SUD) or depression are among those at highest risk for a serious prescription opioid overdose, according to a study published in Pain Medicine. The retrospective, case-control study analyzed and compared patients with an opioid prescription from two health care claims databases: the U.S. […]

Naloxone Access in Community Pharmacies

Eleven states are already allowing unilateral dispensing of Naloxone by a pharmacist. Most others allow dispensing without prescription or have standing order policies.  Only five states have not allowed special access to naloxone. This link shows an updated map of naloxone access in community pharmacies across the United States, as of […]

NYTimes: Inside a Killer Drug Epidemic: A Look at America’s Opioid Crisis

The opioid epidemic killed more than 33,000 people in 2015. What follows are stories of a national affliction that has swept the country, from cities on the West Coast to bedroom communities in the Northeast. Read the article here.

Fentanyl Fraud

Interesting article on a fentanyl (Subsys) scam that is worth a read. There is substantial focus on fentanyl currently; this kind of “pill-mill” and pay-for-prescribing behavior drives focus and decision-making for payers and for regulators. This article presents a slightly different angle on the opioid challenge.

Venebio featured on the cover of the Richmond Times-Dispatch Metro Business Section

Venebio Group, LLC, was featured on the cover of the Richmond Times-Dispatch Metro Business Section. The accompanying article highlights the recent $1.5 million NIH grant for continual development of the Venebio Opioid Advisor. Click here to read the full article.

Venebio receives SBIR grant to fight opioid epidemic

Venebio received a $1.5M SBIR grant from the National Institute on Drug Abuse to continue its development of the Venebio Opioid Advisor and fight the national opioid epidemic. Read the full news release here.